NIVOLUMAB (OPDIVO®) SUBSIDIZED

$1,700.00$19,800.00

What Is Nivolumab (Opdivo)?

  • A checkpoint inhibitor, a type of immunotherapy that helps make cancer cells more vulnerable to attack by your body’s own immune system
  • An antibody that promotes the tumor-killing effects of T cells (white blood cells that help your body fight disease)
  • It is used to treat advanced melanoma that is unresectable or has spread to organs and other parts of the body. In addition, nivolumab is also used as adjuvant therapy, that is, treatment after complete surgical resection of melanoma to reduce the risk of the melanoma returning. To learn more about the use of nivolumab as adjuvant therapy for melanoma.
Clear